- Accesswire•yesterdayAdvanced Medical Isotope's CEO Releases Shareholder Letter Announcing and Discussing their Cancer Indication Selection to Pursue for FDA Approval
Basal cell carcinoma and squamous cell carcinoma (skin cancers) selected, representing over 5,500,000 diagnoses annually in the US alone, making it the most prevalent cancer today KENNEWICK, WA / ACCESSWIRE ...
- Accesswire•15 days agoAdvanced Medical Isotope's CEO Releases Shareholder Letter Outlining New Streamlined Path to FDA Submission
Hires Expert FDA Device Submission Firm; Outlines In-Parallel FDA Data Collection Strategy; Expands Medical Advisory Board with Doctors from 2 Top Cancer Hospitals; Narrows Indication List from 18 to 6 ...
- GuruFocus.com•last month
CEO buys 700,000 shares of the company
ADMD : Summary for ADVANCED MEDICAL ISO - Yahoo Finance
Advanced Medical Isotope Corporation (ADMD)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.16 - 0.17|
|52 Week Range||0.07 - 1.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.34|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|